OR52P2P

Across TCGA pan-cancer cohorts, OR52P2P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR52P2P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where OR52P2P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR52P2P is over-expressed in tumor.

STAD and PRAD are the cancer types where OR52P2P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR52P2P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	+0.026	.035	2	view →
PRAD	All	All	+0.014	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

OR52P2P–STAD

Open the STAD breakdown →